Clinical Trial

Normobaric Oxygen in AIS Transferred for EVT

Study acronym: AN-O2
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to estimate the efficacy and safety of NBO on 3-month functional outcome after acute ischemic stroke
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-10-29; most recent amendment 2025-12-04.
Status change: Not Yet Recruiting → Recruiting 2024-12-13
Trial Details
NCT Number NCT06666764
Lead Sponsor Capital Medical University
Conditions Ischemic Stroke
Enrollment 1,500 participants
Start Date 2024-12-13
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2025-12-11